Estrogens have been linked to a higher female incidence of autoimmune diseases. The role of androgen and the androgen receptor (AR) in autoimmune diseases, however, remains unclear. Here we report that the lack of AR in B cells in different strains of mice, namely general AR knockout, B cell-specific AR knockout, and naturally occurring testicular feminization mutation AR-mutant mice, as well as castrated wild-type mice, results in increased B cells in blood and bone marrow. Analysis of the targeted mice, together with bone marrow transplantation using Rag1 Ϫ/Ϫ recipients, overexpression of retrovirally encoded AR-cDNA, and small interfering RNA-mediated AR mRNA knockdown approaches also show that the B cell expansion results from resistance to apoptosis and increased proliferation of bone marrow precursor B cells, accompanied by changes in several key modulators related to apoptosis, such as Fas/FasL signals, caspases-3/-8, nuclear factor-B, and Bcl-2. We also show that the effects of AR loss are, in part, B cell intrinsic. Mice bearing AR-deficient B cells show increased levels of serum IgG2a and IgG3 as well as basal double-stranded DNA-IgG antibodies and are more vulnerable to development of collagen-induced arthritis. Together, these data indicate that androgen/AR play a crucial role in B cell homeostasis and tolerance. Therapies targeting AR might provide an alternative strategy with which to battle autoimmune diseases. 1, 2) is a member of the nuclear receptor superfamily (3, 4) the role of which in B cell development and function is unclear. Early studies suggest that both B cells and stromal cells within the bone marrow express AR (5, 6) and that castration or AR mutations in mice result in increased B cells in the peripheral blood (7, 8) . The inhibitory effect of sex hormones on B cells is required for the function of the hormone receptors (8). The intrinsic effects of androgens and influence of AR mutations on B cell development within bone marrow, however, remain to be elucidated.
Estrogens have been linked to a higher female incidence of autoimmune diseases. The role of androgen and the androgen receptor (AR) in autoimmune diseases, however, remains unclear. Here we report that the lack of AR in B cells in different strains of mice, namely general AR knockout, B cell-specific AR knockout, and naturally occurring testicular feminization mutation AR-mutant mice, as well as castrated wild-type mice, results in increased B cells in blood and bone marrow. Analysis of the targeted mice, together with bone marrow transplantation using Rag1 Ϫ/Ϫ recipients, overexpression of retrovirally encoded AR-cDNA, and small interfering RNA-mediated AR mRNA knockdown approaches also show that the B cell expansion results from resistance to apoptosis and increased proliferation of bone marrow precursor B cells, accompanied by changes in several key modulators related to apoptosis, such as Fas/FasL signals, caspases-3/-8, nuclear factor-B, and Bcl-2. We also show that the effects of AR loss are, in part, B cell intrinsic. Mice bearing AR-deficient B cells show increased levels of serum IgG2a and IgG3 as well as basal double-stranded DNA-IgG antibodies and are more vulnerable to development of collagen-induced arthritis. Together, these data indicate that androgen/AR play a crucial role in B cell homeostasis and tolerance. Therapies targeting AR might provide an alternative strategy with which to battle autoimmune diseases. (1, 2) is a member of the nuclear receptor superfamily (3, 4) the role of which in B cell development and function is unclear. Early studies suggest that both B cells and stromal cells within the bone marrow express AR (5, 6) and that castration or AR mutations in mice result in increased B cells in the peripheral blood (7, 8) . The inhibitory effect of sex hormones on B cells is required for the function of the hormone receptors (8) . The intrinsic effects of androgens and influence of AR mutations on B cell development within bone marrow, however, remain to be elucidated.
Many autoimmune diseases are known to display a strong association with the female, and sex hormones including androgen have been shown to exert a number of immunoregulatory activities in B lymphocytes (9, 10) . The causal relationship between sex hormones and susceptibility to autoimmunity is consistent with the observation that male rheumatoid arthritis patients display low levels of androgens (11) (12) (13) and that prostate cancer patients treated with androgen-ablation therapy were reported to have an increased incidence of rheumatoid arthritis (14) .
To further address the role of AR function in B cell development and the relationship of AR to the incidence of autoimmune disease, we applied conditional knockout strategies to ablate AR function in B cells. We found that the lack of AR influenced B cell numbers in the bone marrow, peripheral blood, and spleen. B cell ontogeny studies revealed that loss of AR affected the development of immature B cells in the bone marrow. The increased number of B cells was associated with the inhibition of apoptosis via Fas/Fas ligand (FasL) and caspase pathways. In addition, we show that collagen-induced arthritis (CIA) is more severe in mice bearing AR-deficient B cells compared with wild-type (Wt) controls, suggesting that AR might play an important role in the regulation of B cell tolerance in specific autoimmune diseases.
Results

General AR knockout mice (G-ARKO) have increased B cells in blood and bone marrow
G-ARKO (C57BL6/FVB) mice, bearing a deletion of the AR DNA-binding domain (Fig. 1A) , were obtained using a previously reported conditional Cre-lox recombination-based strategy (15) and confirmed through genotyping of tail snips (Fig. 1,  A and B) . RT-PCR analysis of G-ARKO bone marrow B cells showed the diagnostic alteration of AR mRNA (Fig. 1C) . Loss of AR protein expression in bone marrow B cells was confirmed by flow cytometry analysis (Fig. 1D ). Automated analysis of hematological parameters showed no significant difference between G-ARKO and Wt mice in red blood cells, platelets, hemoglobin, hematocrit (data not shown), and total white blood cells (Fig. 1E ), but the total number of lymphocytes was significantly increased in G-ARKO mice compared with Wt mice (Fig. 1E ).
Loss of AR in different strains of mice results in increased developing bone marrow B cells
Flow cytometry analysis of the distribution and the absolute number of B cell subpopulations within the bone marrow showed that B220 low (B220: antigen high-molecular weight glycoproteins uniquely expressed on the surface of B cells and their hemopoietic progenitors) developing B cells are increased in G-ARKO compared with Wt mice (Fig. 2A) . This suggests that the observed increase in peripheral blood lymphocytes of G-ARKO mice (Fig.  1E ) might be due to increased production of B cells in the bone marrow. The observed increase in the developing immature B cell fraction of G-ARKO mice is comparable to that observed in testicular feminization mutation (Tfm) mice (C57BL/6J-ATa) that carry a naturally defective AR gene (16) (Fig. 2B) , and in castrated BALB/c mice (Fig. 2C) . Implantation of dihydrotestosterone (DHT) pellets resulted in normal bone marrow B cell levels in castrated mice (Fig. 2D, left panel, vs. Fig. 2C, middle panel) but not in G-ARKO mice (Fig. 2D , middle panel, vs. Fig. 2A , middle panel) and summary in Table 1 . Thus, data from three independent experimental mouse models demonstrate an essential role for AR in the maintenance of B cell development homeostasis.
Intrinsic effects of AR ablation on developing B cells
To determine whether the effect on immature B cell accumulation observed in the AR deficiency models described above . B, Genotyping of tissue DNA isolated from G-ARKO and Wt littermates using "select and 2-9" primers; 600 bp represents Wt AR and 270 bp represents G-ARKO. C, We used the primers 5Ј-AATGGGACCTTGGATGGAGAAC-3Ј and 5Ј-TCCCTGCTTCATAACATTTCCG-3Ј for RT-PCR, to obtain an AR transcript of 305 bp from Wt AR, but only 153 bp when exon 2 is deleted. Full-length AR mRNA is not expressed in B cells from the bone marrow of G-ARKO mice. D, FACS analysis shows intracellular AR protein is not detected in B cells from the bone marrow of G-ARKO mice. E, Automated blood analysis shows peripheral blood lymphocytes, but not total white blood cells (WBC), are increased in G-ARKO (n ϭ 24) compared with Wt (n ϭ18). Data are mean Ϯ SD. *, P Ͻ 0.05.
was due only to an effect of AR on the bone marrow compartments and intercellular signals that direct B cell development or to an intrinsic effect of androgen/AR on developing B cells, we performed bone marrow transplantation experiments. We used Rag1 Ϫ/Ϫ mice, in which B cell development is blocked due to loss of Ig gene rearrangements (17) , but the bone marrow microenvironment is intact. B cells from bone marrow isolated from Wt and G-ARKO mice were transplanted into 5-wk-old Rag1 Ϫ/Ϫ mice. After 8 wk, the bone marrow in the Rag 
Increased B cells in bone marrow in B cell-specific AR knockout (B-ARKO) mice
To further characterize the potential intrinsic role of androgen/AR during B cell maturation and development, we generated B cell-specific AR knockout mice (B-ARKO) by mating floxed-AR female mice with male mice expressing Cre recombinase under the control of the CD19 promoter (18) . PCR amplification of the critical AR gene region from genomic DNA isolated from B cells from bone marrow and spleen, with thymus and kidney as control genomic DNA, revealed essentially complete Cre-mediated deletion at the single, X-linked AR locus in these mice (Fig. 3D) ; this was confirmed by loss of AR protein expression in bone marrow B cells, as established by flow cytometry analysis (Fig. 3E) . Increased B cells were again observed in B-ARKO blood ( Fig. 3F ) and bone marrow (Fig. 3G ). B220 low developing B cells are specifically increased in the bone marrow of B-ARKO mice compared with Wt mice (Fig. 3 , H-J, and Table 1 ). We also saw a slight increase of B cells in the blood and significant increase in bone marrow of B-ARKO. In all cases, however, these differences are less pronounced in B-ARKO than in G-ARKO mice.
Developmental stage distribution of B cells in bone marrow and periphery of G-ARKO, B-ARKO, and Wt mice
B cell development occurs in stages characterized by distinct combinations of cell surface markers and gene expression patterns 
Resistance to apoptosis in AR-deficient B cells
Apoptosis plays a crucial role during B cell development and in the establishment of B cell tolerance (20, 21) . To determine whether the observed increase in AR-deficient precursor B cells could be attributed to apoptosis resistance, we measured spontaneous apoptosis in Wt, G-ARKO, and B-ARKO bone marrow B cells cultured in vitro in the presence of IL-7. A significant decrease in the number of G-ARKO and B-ARKO apoptotic B cells compared with Wt B cells was observed after 14 d by 7-amino actinomycin D (7-AAD) staining (22) (Fig. 5A ), and at 48 h, there was a significant decrease in the number of G-ARKO and B-ARKO apoptotic B cells as detected by TUNEL assays (23) (Fig. 5B) . Concomitantly with diminished apoptosis, caspase-3 and caspase-8 activities were decreased in B cells from G-ARKO mice compared with Wt mice (Fig. 5, C-E) . Furthermore, the expression of Fas protein (Fig. 5F ) was decreased in B cells from G-ARKO and B-ARKO mice compared with Wt mice.
Next, we tested whether the absence of AR signaling might affect B cell proliferative capacity in vivo. G-ARKO, B-ARKO, and Wt (control mice) were injected ip with bromodeoxyuridine (BrdU) and B cells were analyzed for BrdU incorporation by fluorescenceactivated cell sorting (FACS) (24) . B220-low bone marrow precursor B cells from G-ARKO mice were found to have substantially higher (11.81 to 25.82%) BrdU incorporation compared with Wt mice (Fig. 5, G and H) . G-ARKO, B-ARKO, and B-ARKO mice bone marrow B cells cultured in vitro in the presence of IL-7, which is positively linked to proliferation, also had higher numbers of B cells than similarly cultured Wt cells (Fig. 5, I and K). Antiapoptotic markers, such as nuclear factor-B (NF-B) (p65) (25) and Bcl-2 (26), were up-regulated in G-ARKO and B-ARKO B cells compared with Wt mice (Fig. 5J) . These results were further confirmed by higher expression of proliferating cell nuclear antigen (27) in G-ARKO and B-ARKO precursor B cells (Fig. 5J) . G-ARKO and B-ARKO mice bone marrow B cells cultured in vitro in the presence of IL-7 also had higher thymidine incorporation (28) than similarly cultured Wt cells (Fig. 5K) . Together, these results suggest that both resistance to apoptosis via modulation of several apoptotic factors and increased proliferation in developing B cells are likely to account for the expansion of developing B cells observed in G-ARKO and B-ARKO mice.
Bone marrow retroviral transfection with either AR-small interfering RNA (siRNA) or AR-cDNA confirms the role of AR in B cell homeostasis
We transfected CV-1 cells (used to test siRNA efficiency) with pBabe-AR and pSuperior-AR-siRNA to demonstrate increased or suppressed endogenous AR function via transactivation assays (Fig. 5L) . We then used the same vectors to transduce bone marrow B cell precursors from normal and G-ARKO mice and performed in vitro colony formation assays in the presence of IL-7 (16) (Fig. 5M) and AR expression by Western blot (Fig. 5N) .
Increased immunoglobulin concentration in the serum of G-ARKO and B-ARKO mice
A potential consequence of alteration of B cell homeostasis is the development of autoimmune disease (29) . Serum concentrations of IgG3 and IgG2a in G-ARKO mice and IgG3 in B-ARKO mice were significantly increased compared with Wt mice (Fig.  6, A-D) . G-ARKO and B-ARKO mice also displayed little difference in the double-stranded DNA (dsDNA)-IgM (Fig. 6E) and significantly elevated levels of serum IgG autoantibodies to dsDNA, a hallmark of autoimmune susceptibility (Fig. 6F) .
Loss of AR in B cells promotes development of CIA
Previously, a report showed that ARKO might contribute to the development of type 2 diabetes (30). Thus, we hypothesize that ARKO mice might develop spontaneous autoimmune diseases such as lupus. The sera levels of IgG-dsDNA were positive, but the clinical scores were negative. Therefore, we immunized ARKO mice with ds-DNA (31) and the clinical score for lupus (IgG glomerular deposits and glomerulonephritis) were negative (data not shown). Furthermore, we tested whether B cell expansion and increase in basal IgG-rheumatoid factor (IgG-RF) autoantibody levels in G-ARKO and B-ARKO mice are associated with developing RA. Both G-ARKO and B-ARKO mice were observed to have an increase in the IgG-RF, but no rheumatoid arthritis clinical score has been observed (data not shown). Therefore, we immunized ARKO and B-ARKO mice with bovine (b) collagen II (CII) and followed them for 10 wk to assess development of CIA (32) .
As shown in Fig. 7 , we found that CIA incidence (Fig. 7A ) and clinical scores (Fig. 7B) were increased in G-ARKO, B-ARKO, and Wt mice. Figure 7C shows external joint phenotype after inducing arthritis, and Fig. 7 , D and E, shows histological evidence of significant CIA manifestations in both G-ARKO and B-ARKO mice compared with Wt mice, including enlarged synovial membrane and lymphocyte infiltration. Also, concentrations of IgG-RF, a marker of ongoing autoimmune disease, were significantly elevated in both G-ARKO and B-ARKO mice compared with Wt mice (Fig. 7F) .
Moreover, after immunization, we measured the CII-specific antibody (Ab) by ELISA. Mice were immunized with CII and, after 21 d immunization, the sera were collected and analyzed for the presence of total Ab of bCII (bCII-specific) (Fig. 8A) , murine (m) CII (mCII-specific) (Fig. 8B) , and analysis of isotype expression in the mCII-specific Ab response (Fig. 8, C-F) . mCII-specific isotypes were quantitated using the sera described in Fig. 8A and a solidphase ELISA in which the detection Abs were specific for the isotypes listed. These results show that loss of AR in B cells renders mice more vulnerable to develop autoimmune diseases, although this effect is less pronounced than in mice with ubiquitous loss of AR. 
Discussion
Defects in androgen/AR have been shown to cause a variety of effects on B cell development and maturation (8, 9) . Here, we show, for the first time, that some of these defects are, in part, intrinsic to B cells and can result in increased susceptibility to autoimmune disease. Using three different strains of mice (B-ARKO, G-ARKO, and natural AR gene defect in Tfm mice), as well as shown that loss of estrogen receptor results in increased B cells in female, but not male, mice (33) . In addition, estrogen treatment of castrated male mice has been shown to increase the production of autoantibodies (9) , which together with our data suggests that androgen/AR might be sufficient for maintaining normal B cell homeostasis in estrogen receptor-deficient male mice.
Using reciprocal bone marrow transplantation experiments in Tfm mice, Olsen and colleagues (8, 9, 34) have shown that AR deficiency in the bone marrow stroma, rather than B cells, is responsible for the expansion of precursor B cell populations in that strain. Although those results are different from ours, the finding that B-ARKO mice display a similar phenotype to that of G-ARKO mice quite clearly demonstrates that AR has intrinsic effects on B cells. Nevertheless, because all observed phenotypes are milder in B-ARKO than in G-ARKO mice, the evidence clearly supports a role for non-B cell components, including stromal cells, but also possibly T cells and nonlymphoid populations. Targeted inactivation of AR in candidate cellular subsets, using strategies analogous to those used in this report, will be required to unravel the pleiotropic role of AR in immune homeostasis.
As far as the B cell-specific effects are concerned, several mechanisms seem to contribute to the increased B lymphopoiesis in the absence of AR. First, our results suggest an increased number of IL-7-responsive early B cell precursors in bone marrow from AR-deficient mice. Second, based on BrdU incorporation experiments, AR-deficient developing B cells display higher proliferative rates compared with controls. Finally, a number of factors involved in the regulation of apoptosis, including Fas/FasL, caspases-3/-8, and antiapoptotic mediators appear dysregulated in AR-deficient B cells. Moreover, it is possible that the AR up-regulates apoptosis signal pathways such as caspases or Fas/FasL pathways (Fig. 5, C-F) or down-regulates the proliferative signal such as NF-kB/p65, Bcl2, and proliferating cell nuclear antigen (Fig. 5, I and J). The expansion of B cells in the periphery of G-ARKO mice could be due to the failure of the peripheral compartment to compensate for the increased influx of newly developed B cells from the bone marrow.
Overall, the results of the present study suggest that androgen/AR might influence immune function, in part, by affecting the primary B cell repertoire, because removal of AR results in a larger and possibly more diverse population of B lymphocytes in terms of androgen specificities. Because of reduced apoptosis, the expanded population of B cells in AR-deficient mice could include cells with autoreactive specificities, thus providing a conceptual mechanistic link between loss of AR and development of autoimmune diseases. This hypothesis is consistent with our findings of enhanced basal anti-dsDNA-IgG levels in G-ARKO mice. Most strikingly, increased susceptibility to CIA in G-ARKO mice underscores the essential role of androgen in preventing autoimmune pathologies.
Rheumatoid arthritis is believed to be triggered by exposure of a genetically susceptible host to an arthrogenic antigen and subsequent autoimmune chronicity and progression (35, 36) . Ultimately, joint destruction results from activation of T and B lymphocytes and local release of inflammatory mediators and cytokines. The target antigens and the mechanisms of lymphocyte activation are still largely unknown. Increasing evidence suggests that immune complex deposition might play a role in joint destruction (37) . Rheumatoid arthritis patients, as well as models of autoimmune arthritis such as murine CIA, demonstrate defective B cell apoptotic pathways and tolerance checkpoints that result in the accumulation of autoreactive naïve B cells in the blood (26) . Impaired B cell tolerance checkpoints might be a common feature in many rheumatic diseases (38) . Low levels of androgens have been found in male rheumatoid arthritis patients (12, 13) and case reports have suggested that androgen ablation therapy to suppress AR function in prostate cancer might be a risk factor for development of rheumatoid arthritis (14) . Moreover, Cutolo et al. (39) found that androgen replacement therapy improved clinical and immunological parameters associated with rheumatoid arthritis. Ellis et al. (40) also showed similar results after androgen ablation.
Together, these human clinical data support our finding that loss of AR in B cells, using G-ARKO and B-ARKO mice, results in the expansion of B cells that can contribute to the development of selective autoimmune disease, such as CIA. Therefore, AR might become a new target to treat these selective autoimmune disease.
Materials and Methods
Mice
Construction of targeting vectors and generation of the chimera founder mice have been previously described (15) . We generated floxed AR mice with a nearly pure C57BL/6 background by backcrossing the original C57BL6/129 background floxed AR mice with pure C57BL/6 background mice for more than eight generations. ␤-Actin is constitutively and ubiquitously expressed; thus, the ␤-actin promoter-driven ACTB Cre in the FVB background, and CD19Cre in the B6 background (The Jackson Laboratory, Bar Harbor, ME) will express and delete floxed AR fragments in all the tissues and B-cells, respectively. Wt and ARKO mice were genotyped by PCR as described previously (15) . Male BALB/c mice, Rag Ϫ/Ϫ , and male Tfm mice, as well as Wt control mice [C57BL/6J-Ata 6J)ϩ/Y], were purchased from The Jackson Laboratory.
Androgen supplementation
We achieved androgen supplementation in castrated Wt mice and G-ARKO littermates by sc implantation of 21-d time-release pellets (Innovative Research of America) containing DHT (5 mg per pellet); mice were killed 14 d after androgen supplementation. Levels of plasma DHT were determined by a DHT ELISA Kit (Alpha Diagnostic International, San Antonio, TX) according to the manufacturer's protocol.
Cytology and automated hematology analysis
We measured hematological parameters from blood samples obtained from 8-to 12-wk-old mice using an Abbott CELL-DYN 4000 system.
Cell staining and isolation using flow cytometry
We performed immunofluorescence analysis using fluorochromeconjugated antibodies purchased from eBiosciences, including APC-an- 
Adoptive transfer of B cells
We used ARKO and Wt mice at 8 -10 wk of age as bone marrow B cell donors. The B cells from the bone morrow were purified by using B220 ϩ markers, after which the purity of the B cell bone marrow was tested (see Fig. 3A ). The purified G-ARKO and Wt bone marrow B cells (B220 To assess levels of in vivo proliferation, mice received a 1 mg ip injection of BrdU suspended in PBS. B cells (B220 ϩ ) were fixed and then incubated with an anti-BrdU Ab conjugated to FITC (anti-BrdU-FITC) for flow cytometry. Cells were cultured for 4 d in MesenCult medium supplemented with IL-7 after which cell viability by dimethyl thiazolyl blue tetrazolium bromide assay was performed. At the indicated time points, media were removed and serum-free media containing dimethyl thiazolyl blue tetrazolium bromide (0.5 mg/ml; Sigma Chemical Co., St. Louis, MO) were then added into each well. After 4 h incubation at 37 C, cellular formazan product was dissolved with acidic isopropanol, and the absorbance at OD 595 was measured by spectrophotometry (Beckman Du640B).
Construction of mouse pBabe-AR and pSuperior-ARsiRNA
Oligonucleotides (5Ј-CGGAATTCGTGGAAGCT-3Ј and 5Ј-GAAA-GATCTACA-TCAGTAGAGG-3Ј) were used to clone mouse AR frag- ments from mouse prostate cDNA library using PCR. The retroviral vector pBabe-AR was constructed by ligating the BamHI/Bgl II-digested PCR product into BamHI/BglII-digested pBabe-puro vector. The pSuperiorgreen fluorescent protein (GFP) vector for expression of siRNA was purchased from OligoEngine (Seattle, WA). To generate pSuperior-GFP-ARsiRNA, the pSuperior-GFP vector was digested with BglII and HindIII, and the annealed oligonucleotides were ligated into the vector. The 19-nucleotide sequences for targeting mouse AR were: 5Ј-GATCCC-CTCTAGCCTCAATGAGCTTGTTCAAGAGACAAGC-TCATTGAGGCTAGATTTTTA-3Ј and 5Ј-AGCTTAAAAATCTAGC-CTCAATGAGCTTGTCTCTTGAACAAG-CTCATTGAGGCTAGA-GGG-3Ј; pSuperior-GFP-AR scramble siRNA control plasmid will be constructed.
Transient transfections and reporter gene assays
We performed transfections using SuperFect and carried out Luciferase (Luc) assays as described previously (25) . Briefly, we plated 1-4 ϫ 10 5 cells on 35-or 60-mm dishes 24 h before adding the DNA precipitation mix containing androgen response element-Luc reporter plasmid DNA. We changed the medium to phenol-red-free RPMI 1640 with 10% charcoalstripped fetal calf serum 1 h before transfection. In each experiment, we equalized the total amount of transfected DNA per dish by the addition of empty expression vector (pCMV) to make a total of 10 g/60-mm dish. We determined Luc activity using a Dual-Luciferase Reporter Assay System (Promega Corp., Madison, WI) and a luminometer.
Collagen-induced arthritis (CIA)
ARKO mice and Wt littermates were injected intradermally at four sites on the flanks with 200 l containing 200 g of bCII (32) . The incidence of arthritis reflects the development of disease in any paw (limb). Between d 21 and d 70, two trained laboratory personnel examined the mice three times weekly (blinded as to strain of mouse). A three-point scale was used for each paw: 0 ϭ normal joint; 1 ϭ slight inflammation and redness; 2 ϭ severe erythema and swelling affecting the entire paw; and 3 ϭ deformed paw or joint with ankylosis, joint rigidity, and loss of function. Our data present the clinical score from the average of all four limbs per animal.
Histological examination
We prepared the tissue samples for histological examination as previously described (15) . We scored the joint sections for changes in synovial inflammation, pannus, cartilage damage, and bone damage, all on a scale of 0 -5, with an overall score calculated as the total of the four individual parameters. We present the compiled data for six G-ARKO mice and six Wt mice as the mean Ϯ SD based upon a set of four joints per animal.
ELISA
We used a sandwich ELISA for Ig isotype determination in serum for determination of specific antibodies after immunization (30) .
Statistics
We presented data as the mean Ϯ SD, making comparisons between groups using a two-sided Student's t test. P values Ͻ 0.05 were considered significant.
Other methods
We performed RT-PCR and Western blotting assays as previously described (1).
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